Presentation TCT 2017 Bioresorbable Scaffolds One Year After Approval: Physician-scientist Perspectives on Current and Future BRS Presenter: Gregg W. Stone October 31, 2017 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2017 DES/BRS/DCB Up Next Presentation TCT 2017 Bioresorbable Scaffolds One Year After Approval: FDA Perspectives on Current and Future BRS Presenter: Andrew Farb October 31, 2017 More slides + Presentation TCT 2017 XINSORB: A Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease Presenter: Junbo Ge October 31, 2017 Presentation TCT 2017 VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI Presenter: David Erlinge October 31, 2017 We Recommend
Presentation TCT 2017 Bioresorbable Scaffolds One Year After Approval: FDA Perspectives on Current and Future BRS Presenter: Andrew Farb October 31, 2017
Presentation TCT 2017 XINSORB: A Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease Presenter: Junbo Ge October 31, 2017
Presentation TCT 2017 VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI Presenter: David Erlinge October 31, 2017